Sign Up Today and Learn More About Alebund Pharmaceuticals Stock
Invest in or calculate the value of your shares in Alebund Pharmaceuticals or other pre-IPO companies through EquityZen's platform.
Alebund Pharmaceuticals Stock (ALEP)
Alebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases.
About Alebund Pharmaceuticals Stock
Founded
2018
Industries
Software, Artificial Intelligence, Financial Services
Alebund Pharmaceuticals Press Mentions
Stay in the know about the latest news on Alebund Pharmaceuticals
Crystalline forms or salts of a deuterated compound
patents • Feb 07, 2025
DEUTERATED COMPOUNDS
patents • Feb 07, 2025
Aviceda raises $207.5m for eye drug, and other financings
pharmaphorum • Jan 08, 2025
Alebund Pharmaceutical announced the 1st closing of RMB 550 million in Series C financing
biospace • Jan 08, 2025
Alebund Pharmaceutical announced the 1st closing of RMB 550 million in Series C financing
en • Jan 07, 2025
Alebund Pharmaceuticals Management
Leadership team at Alebund Pharmaceuticals
Co-Founder and Chief Medical Officer
Jin Tian
Co-Founder and Chief Executive Officer
Gavin Xia
Join now and verify your accreditation status to gain access to:
- Alebund Pharmaceuticals Current Valuation
- Alebund Pharmaceuticals Stock Price
- Alebund Pharmaceuticals Management
- Available deals in Alebund Pharmaceuticals and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Alebund Pharmaceuticals Cap Table and Funding History by Share Class and Liquidity Preferences
- Alebund Pharmaceuticals Revenue and Financials
- Alebund Pharmaceuticals Highlights
- Alebund Pharmaceuticals Business Model
- Alebund Pharmaceuticals Risk Factors
- Alebund Pharmaceuticals Research Report from SACRA Research
Trading Alebund Pharmaceuticals Stock
How to invest in Alebund Pharmaceuticals stock?
Accredited investors can buy pre-IPO stock in companies like Alebund Pharmaceuticals through EquityZen funds. These investments are made available by existing Alebund Pharmaceuticals shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Alebund Pharmaceuticals stock?
Shareholders can sell their Alebund Pharmaceuticals stock through EquityZen's private company marketplace. EquityZen's network includes over 370K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
